Development of OXY111A, a novel hypoxia-modifier as a potential antitumor agent in patients with hepato-pancreato-biliary neoplasms - Protocol of a first Ib/IIa clinical trial

Limani, Perparim ; Linecker, Michael ; Kron, Philipp ; Samaras, Panagiotis ; Pestalozzi, Bernhard ; Stupp, Roger ; Jetter, Alexander ; Dutkowski, Philipp ; Müllhaupt, Beat ; Schlegel, Andrea ; Nicolau, Claude ; Lehn, Jean-Marie ; Petrowsky, Henrik ; Humar, Bostjan ; Graf, Rolf ; Clavien, Pierre-Alain

BioMed Central 2016-10

Texto completo disponível